This Article Full Text (PDF) References Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Add to Saved Citations Download to citation manager Request Permissions Request Reprints Add to My Marked Citations Citing Articles Citing Articles via Google Scholar Google Scholar Articles by Sutton, S. W Articles by Wood, R. E Search for Related Content PubMed PubMed Citation Articles by Sutton, S. W Articles by Wood, R. E Social Bookmarking                   What's this?

Cardiopulmonary bypass and mitral valve replacement during pregnancy

Baylor University Medical Center, Dallas, USA, ssutton240{at}aol.com

Michael A Duncan

Baylor University Medical Center, Dallas, USA

Virginia A Chase

Baylor University Medical Center, Dallas, USA

Randy J Marcel

Department of Anesthesiology, Baylor University Medical Center, Dallas, USA

Thomas P Meyers

Department of Thoracic and Cardiovascular Surgery, Baylor University Medical Center, Dallas, USA

Richard E Wood

Department of Thoracic and Cardiovascular Surgery, Baylor University Medical Center, Dallas, USA

Gravid patient cardiopulmonary bypass remains a high- risk procedure with regard to fetal preservation. Maternal mortality is similar to that of the nonpregnant female at 1.5-5%. However, fetal mortality remains high at 16-33%, with an average of 19% over the past 25 years, with no correlation to gestational age. Teratogenesis is a major consideration in the first trimester. Variations in the timing of surgical intervention, gestational age, maternal health status, type of procedure, pre- or post- organogenesis, perfusion protocol, and pharmaceutical therapy are all factors that can influence fetomaternal outcome. In this report, we present a literature review along with our experience of a 26-year-old female who developed complications with her pregnancy at approximately 17 weeks gestation, with adverse neurological sequelae. The patient was 152 cm in height and weighed 48 kg, with a calculated body surface area of 1.40 M². She had no prior history of cardiac disease and, upon admission to our institution, presented with a declining health status in pulmonary edema and was treated medically, with an ultimate requirement for mitral valve replacement. The total cardiopulmonary bypass time was 99 min with an aortic crossclamp time of 83 min. The literature, as expected, is limited to case reports and reviews since a controlled clinical trial during pregnancy is nonexistent, using extracorporeal circulation. This greatly challenges the medical staff in managing such difficult cases, with an incidence of heart disease during pregnancy of 1.2-3.7%.

CiteULike    Connotea    Del.icio.us    Digg    Reddit    Technorati    What's this?